These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
536 related articles for article (PubMed ID: 29608599)
1. Prevalence of mcr-type genes among colistin-resistant Enterobacteriaceae collected in 2014-2016 as part of the INFORM global surveillance program. Wise MG; Estabrook MA; Sahm DF; Stone GG; Kazmierczak KM PLoS One; 2018; 13(4):e0195281. PubMed ID: 29608599 [TBL] [Abstract][Full Text] [Related]
3. Low Frequency of Ceftazidime-Avibactam Resistance among Enterobacteriaceae Isolates Carrying Castanheira M; Mendes RE; Sader HS Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031200 [No Abstract] [Full Text] [Related]
4. Longitudinal analysis of the in vitro activity of ceftazidime/avibactam versus Enterobacteriaceae, 2012-2016. Ramalheira E; Stone GG J Glob Antimicrob Resist; 2019 Dec; 19():106-115. PubMed ID: 31295583 [TBL] [Abstract][Full Text] [Related]
5. Detection of mcr-1 Plasmids in Enterobacteriaceae Isolates From Human Specimens: Comparison With Those in Escherichia coli Isolates From Livestock in Korea. Yoon EJ; Hong JS; Yang JW; Lee KJ; Lee H; Jeong SH Ann Lab Med; 2018 Nov; 38(6):555-562. PubMed ID: 30027699 [TBL] [Abstract][Full Text] [Related]
6. In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018). Piérard D; Stone GG BMC Infect Dis; 2021 Jun; 21(1):600. PubMed ID: 34162341 [TBL] [Abstract][Full Text] [Related]
8. [Results of a multicenter study investigating plasmid mediated colistin resistance genes (mcr-1 and mcr-2) in clinical Enterobacteriaceae ısolates from Turkey]. Sarı AN; Süzük S; Karatuna O; Öğünç D; Karakoç AE; Çizmeci Z; Alışkan HE; Cömert F; Bakıcı MZ; Akpolat N; Çilli FF; Zer Y; Karataş A; Akgün Karapınar B; Bayramoğlu G; Özdamar M; Kalem F; Delialioğlu N; Aktaş E; Yılmaz N; Gürcan Ş; Gülay Z Mikrobiyol Bul; 2017 Jul; 51(3):299-303. PubMed ID: 28929967 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of ceftazidime-avibactam and comparators against Gram-negative bacterial isolates collected in the Asia-Pacific region as part of the INFORM program (2015-2017). Ko WC; Stone GG Ann Clin Microbiol Antimicrob; 2020 Apr; 19(1):14. PubMed ID: 32238155 [TBL] [Abstract][Full Text] [Related]
10. [In Vitro Activity of Ceftazidime-avibactam and Colistin Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates]. Hoşbul T; Aydoğan CN; Kaya S; Bedir O; Gümral R; Albay A Mikrobiyol Bul; 2022 Apr; 56(2):218-229. PubMed ID: 35477226 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of ceftazidime/avibactam against isolates of Enterobacteriaceae collected in European countries: INFORM global surveillance 2012-15. Kazmierczak KM; de Jonge BLM; Stone GG; Sahm DF J Antimicrob Chemother; 2018 Oct; 73(10):2782-2788. PubMed ID: 30010894 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of colistin resistance in clinical isolates of Enterobacteriaceae: A four-year cross-sectional study. Prim N; Turbau M; Rivera A; Rodríguez-Navarro J; Coll P; Mirelis B J Infect; 2017 Dec; 75(6):493-498. PubMed ID: 28919348 [TBL] [Abstract][Full Text] [Related]
13. Prospective study on human fecal carriage of Enterobacteriaceae possessing mcr-1 and mcr-2 genes in a regional hospital in Hong Kong. Chan WS; Au CH; Ho DN; Chan TL; Ma ES; Tang BS BMC Infect Dis; 2018 Feb; 18(1):81. PubMed ID: 29439654 [TBL] [Abstract][Full Text] [Related]
14. Ceftazidime-Avibactam Antimicrobial Activity and Spectrum When Tested Against Gram-negative Organisms From Pediatric Patients: Results From the INFORM Surveillance Program (United States, 2011-2015). Sader HS; Huband MD; Duncan LR; Flamm RK Pediatr Infect Dis J; 2018 Jun; 37(6):549-554. PubMed ID: 29206750 [TBL] [Abstract][Full Text] [Related]
15. Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations. Dupont H; Gaillot O; Goetgheluck AS; Plassart C; Emond JP; Lecuru M; Gaillard N; Derdouri S; Lemaire B; Girard de Courtilles M; Cattoir V; Mammeri H Antimicrob Agents Chemother; 2016 Jan; 60(1):215-21. PubMed ID: 26482307 [TBL] [Abstract][Full Text] [Related]
16. [Investigation of Plasmid Mediated mcr Colistin Resistance Gene in Clinical Enterobacterales Isolates]. Özkaya E; Buruk CK; Tosun İ; Toraman B; Kaklıkkaya N; Aydın F Mikrobiyol Bul; 2020 Apr; 54(2):191-202. PubMed ID: 32723275 [TBL] [Abstract][Full Text] [Related]
17. Microbiological surveillance of plasmid mediated colistin resistance in human Enterobacteriaceae isolates in Romagna (Northern Italy): August 2016-July 2017. Del Bianco F; Morotti M; Pedna MF; Farabegoli P; Sambri V Int J Infect Dis; 2018 Apr; 69():96-98. PubMed ID: 29447913 [TBL] [Abstract][Full Text] [Related]
18. An Improved Medium for Colistin Susceptibility Testing. Gwozdzinski K; Azarderakhsh S; Imirzalioglu C; Falgenhauer L; Chakraborty T J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29514937 [TBL] [Abstract][Full Text] [Related]
19. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay. Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643 [TBL] [Abstract][Full Text] [Related]